Guillain–Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series

•We described GBS symptoms in three infected patients with COVID-19.•The severity of GBS linked to COVID-19 seems considerable in mentioned cases.•AMSAN type of GBS was diagnosed based on electrodiagnostic findings.•GBS must be considered as a rapid progressive neurologic complication of COVID-19. T...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical neuroscience 2021-01, Vol.83, p.119-122
Main Authors: Abolmaali, Meysam, Heidari, Matineh, Zeinali, Marjan, Moghaddam, Parichehr, Ramezani Ghamsari, Mona, Jamshidi Makiani, Mahin, Mirzaasgari, Zahra
Format: Article
Language:English
Subjects:
Aged, 80 and over
Case Report
Coronavirus
COVID-19
COVID-19 - complications
Disease Progression
Facial Paralysis - etiology
Fatal Outcome
Female
Guillain-Barre Syndrome - etiology
Guillain–Barré syndrome
Humans
Male
Middle Aged
Neural Conduction
Neurologic Examination
Quadriplegia - etiology
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•We described GBS symptoms in three infected patients with COVID-19.•The severity of GBS linked to COVID-19 seems considerable in mentioned cases.•AMSAN type of GBS was diagnosed based on electrodiagnostic findings.•GBS must be considered as a rapid progressive neurologic complication of COVID-19. The global SARS-CoV-2 pandemic posed an unprecedented challenge to almost all fields of medicine and Neurology is not an exception. Collecting information about its complications and related conditions will help clinicians to become more confident in managing this disease. Guillain-Barre Syndrome (GBS) is mostly described as a post-infectious phenomenon and its occurrence during acute phase of illness is of interest. GBS has recently been reported during the active phase of COVID-19 for the first time. Severity and fast progression of GBS associated with COVID-19 have also been shown in recent studies. Here we report three cases of GBS during the active phase of COVID-19 with severe symptoms and fast progression to quadriplegia and facial diplegia over 2 days, which led to death in one case due to severe autonomic dysfunction. We suggest SARS-CoV-2 might be associated with rather a severe, rapidly progressive and life-threatening phenotype of GBS.
ISSN:0967-5868
1532-2653
DOI:10.1016/j.jocn.2020.11.013